Image-Guided Biopsy - Carcinoma, Bronchogenic / Diagnosis- Outpatients Clinical Trial
— stasfaOfficial title:
CT Scan Guide Percutaneous Biopsy of Lytic Bone Metastases of Lung Cancer : Pathology Diagnosis and Molecular Biology
| Verified date | December 2017 |
| Source | University Hospital, Grenoble |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
In case of primary lung cancer, bone metastases biopsy can be done in initial diagnosis or
follow-up.
Nevertheless, any study focus on rentability and biopsy complications of lytic bone lesion
for the context of lung cancer.
This study aims to demonstrate that CT scan guide percutaneous biopsy of lytic bone lesion
help to anatomopathologic diagnosis and molecular biology with a low complication rate
inasmuch a lung cancer is suspected.
This study is observational, retrospective, one center
| Status | Active, not recruiting |
| Enrollment | 80 |
| Est. completion date | September 2018 |
| Est. primary completion date | June 2017 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | N/A and older |
| Eligibility |
Inclusion Criteria: - CT scan guide percutaneous biopsy of lytic bone metastases - register on CHU Grenoble Alpes radiology software between January 2010 and June 2017 - Patient who have a clinical context of lung cancer with bone metastases Exclusion Criteria: - Person deprived of liberty by judicial order - Opposition expressed by patient |
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| University Hospital, Grenoble |
Fraser-Hill MA, Renfrew DL. Percutaneous needle biopsy of musculoskeletal lesions. 1. Effective accuracy and diagnostic utility. AJR Am J Roentgenol. 1992 Apr;158(4):809-12. — View Citation
Jelinek JS, Murphey MD, Welker JA, Henshaw RM, Kransdorf MJ, Shmookler BM, Malawer MM. Diagnosis of primary bone tumors with image-guided percutaneous biopsy: experience with 110 tumors. Radiology. 2002 Jun;223(3):731-7. — View Citation
Leffler SG, Chew FS. CT-guided percutaneous biopsy of sclerotic bone lesions: diagnostic yield and accuracy. AJR Am J Roentgenol. 1999 May;172(5):1389-92. — View Citation
Vanderlaan PA, Yamaguchi N, Folch E, Boucher DH, Kent MS, Gangadharan SP, Majid A, Goldstein MA, Huberman MS, Kocher ON, Costa DB. Success and failure rates of tumor genotyping techniques in routine pathological samples with non-small-cell lung cancer. Lung Cancer. 2014 Apr;84(1):39-44. doi: 10.1016/j.lungcan.2014.01.013. Epub 2014 Jan 28. — View Citation
Vieillard MH, Boutry N, Chastanet P, Duquesnoy B, Cotten A, Cortet B. Contribution of percutaneous biopsy to the definite diagnosis in patients with suspected bone tumor. Joint Bone Spine. 2005 Jan;72(1):53-60. — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Rentability of biopsy of lytic bone lesion in anatomopathologic analysis | Rentability of biopsy of lytic bone lesion = 100x (number of sample wich analysed by anatomopathologic /total number of biopsy of lytic bone lesion done) | Analysis between january 2018-september 2018 | |
| Secondary | Rentability of biopsy of lytic bone lesion in molecular biology analysis inas much non small cell epidermoid lung cancer is diagnosed | Rentability of biopsy of lytic bone lesion in molecular biology analysis inas much non small cell epidermoid lung cancer is diagnosed - =100x (number of sample wich analysed by molecular biology /total number of biopsy of lytic bone lesion sent to molecular biology analysis) |
Analysis between january 2018-september 2018 | |
| Secondary | Cell quality in sample of biopsy of lytic bone lesion in molecular biology analysis inas much non small cell epidermoid lung cancer is diagnosed | Cell quality in sample of biopsy of lytic bone lesion in molecular biology analysis inas much non small cell epidermoid lung cancer is diagnosed average percentage of tumour cells in samples |
Analysis between january 2018-september 2018 | |
| Secondary | Complication rate linked to gesture of biopsy of lytic bone lesion | Complication rate linked to gesture of biopsy of lytic bone lesion and descriptive analysis | Analysis between january 2018-september 2018 | |
| Secondary | Impact assessement of biopsy of lytic bone lesion on patient care | Modification of management of lung cancer between before biopsy and after biopsy results | Analysis between january 2018-september 2018 |